BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26073844)

  • 1. Estrogenic endocrine disruptors: Molecular mechanisms of action.
    Kiyama R; Wada-Kiyama Y
    Environ Int; 2015 Oct; 83():11-40. PubMed ID: 26073844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic compounds as exogenous modulators of physiological functions in molluscs: Signaling pathways and biological responses.
    Balbi T; Ciacci C; Canesi L
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Aug; 222():135-144. PubMed ID: 31055067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The estrogen receptor of the gastropod Nucella lapillus: modulation following exposure to an estrogenic effluent?
    Castro LF; Melo C; Guillot R; Mendes I; Queirós S; Lima D; Reis-Henriques MA; Santos MM
    Aquat Toxicol; 2007 Oct; 84(4):465-8. PubMed ID: 17727972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Importance of development of ecotoxicogenomics in understanding molecular mechanisms of chemicals in developing animals].
    Iguchi T
    Nihon Eiseigaku Zasshi; 2006 Jan; 61(1):11-8. PubMed ID: 16506650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Estrogenic Bioactivity of Environmental Chemical Metabolites.
    Pinto CL; Mansouri K; Judson R; Browne P
    Chem Res Toxicol; 2016 Sep; 29(9):1410-27. PubMed ID: 27509301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmaco- and toxicokinetics of selected exogenous and endogenous estrogens: a review of the data and identification of knowledge gaps.
    Mattison DR; Karyakina N; Goodman M; LaKind JS
    Crit Rev Toxicol; 2014 Sep; 44(8):696-724. PubMed ID: 25099693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EADB: an estrogenic activity database for assessing potential endocrine activity.
    Shen J; Xu L; Fang H; Richard AM; Bray JD; Judson RS; Zhou G; Colatsky TJ; Aungst JL; Teng C; Harris SC; Ge W; Dai SY; Su Z; Jacobs AC; Harrouk W; Perkins R; Tong W; Hong H
    Toxicol Sci; 2013 Oct; 135(2):277-91. PubMed ID: 23897986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases.
    Preciados M; Yoo C; Roy D
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27983596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple receptors shape the estrogen response pathway and are critical considerations for the future of in vitro-based risk assessment efforts.
    Miller MM; McMullen PD; Andersen ME; Clewell RA
    Crit Rev Toxicol; 2017 Aug; 47(7):564-580. PubMed ID: 28675057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental signaling: from environmental estrogens to endocrine-disrupting chemicals and beyond.
    McLachlan JA
    Andrology; 2016 Jul; 4(4):684-94. PubMed ID: 27230799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extranuclear-initiated estrogenic actions of endocrine disrupting chemicals: Is there toxicology beyond paracelsus?
    Nadal A; Fuentes E; Ripoll C; Villar-Pazos S; Castellano-Muñoz M; Soriano S; Martinez-Pinna J; Quesada I; Alonso-Magdalena P
    J Steroid Biochem Mol Biol; 2018 Feb; 176():16-22. PubMed ID: 28159674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An exposure:activity profiling method for interpreting high-throughput screening data for estrogenic activity--proof of concept.
    Becker RA; Friedman KP; Simon TW; Marty MS; Patlewicz G; Rowlands JC
    Regul Toxicol Pharmacol; 2015 Apr; 71(3):398-408. PubMed ID: 25656492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA microarray-based gene expression profiling of estrogenic chemicals.
    Kiyama R; Zhu Y
    Cell Mol Life Sci; 2014 Jun; 71(11):2065-82. PubMed ID: 24399289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogenic activity of cylindrospermopsin and anatoxin-a and their oxidative products by Fe
    Liu J; Hernández SE; Swift S; Singhal N
    Water Res; 2018 Apr; 132():309-319. PubMed ID: 29339303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Agrochemicals with estrogenic endocrine disrupting properties: Lessons Learned?
    Vandenberg LN; Najmi A; Mogus JP
    Mol Cell Endocrinol; 2020 Dec; 518():110860. PubMed ID: 32407980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endocrine disruptors in marine organisms: approaches and perspectives.
    Porte C; Janer G; Lorusso LC; Ortiz-Zarragoitia M; Cajaraville MP; Fossi MC; Canesi L
    Comp Biochem Physiol C Toxicol Pharmacol; 2006 Jul; 143(3):303-15. PubMed ID: 16723279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained reprogramming of the estrogen response after chronic exposure to endocrine disruptors.
    Patterson AR; Mo X; Shapiro A; Wernke KE; Archer TK; Burd CJ
    Mol Endocrinol; 2015 Mar; 29(3):384-95. PubMed ID: 25594248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The estrogenic activity of resveratrol: a comprehensive review of
    Qasem RJ
    Crit Rev Toxicol; 2020 May; 50(5):439-462. PubMed ID: 32744480
    [No Abstract]   [Full Text] [Related]  

  • 19. Estrogenicity of food-associated estrogenic compounds in the fetuses of female transgenic mice upon oral and IP maternal exposure.
    Ter Veld MG; Zawadzka E; Rietjens IM; Murk AJ
    Reprod Toxicol; 2009 Apr; 27(2):133-9. PubMed ID: 19429392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro modulation of intracellular receptor signaling and cytotoxicity induced by extracts of cyanobacteria, complex water blooms and their fractions.
    Stěpánková T; Ambrožová L; Bláha L; Giesy JP; Hilscherová K
    Aquat Toxicol; 2011 Oct; 105(3-4):497-507. PubMed ID: 21903046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.